SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'BR7'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RQW_A_ACHA323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 5 / 9 | GLU A 77ILE A 79GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.70A | 3rqwA-4twfA:33.03rqwB-4twfA:33.0 | 3rqwA-4twfA:99.353rqwB-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RQW_B_ACHB323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 5 / 9 | GLU A 77ILE A 79GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.68A | 3rqwB-4twfA:33.03rqwC-4twfA:33.0 | 3rqwB-4twfA:99.353rqwC-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RQW_C_ACHC323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 8 | GLU A 77GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)BR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.67A | 3rqwC-4twfA:33.03rqwD-4twfA:33.0 | 3rqwC-4twfA:99.353rqwD-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RQW_D_ACHD323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 5 / 9 | GLU A 77ILE A 79GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.67A | 3rqwD-4twfA:33.03rqwE-4twfA:33.0 | 3rqwD-4twfA:99.353rqwE-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RQW_E_ACHE323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 5 / 9 | GLU A 77ILE A 79GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.67A | 3rqwA-4twfA:33.03rqwE-4twfA:33.0 | 3rqwA-4twfA:99.353rqwE-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RQW_F_ACHF323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 5 / 9 | GLU A 77ILE A 79GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.68A | 3rqwF-4twfA:33.03rqwG-4twfA:33.0 | 3rqwF-4twfA:99.353rqwG-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RQW_G_ACHG323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 5 / 9 | GLU A 77ILE A 79GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.67A | 3rqwG-4twfA:33.03rqwH-4twfA:33.0 | 3rqwG-4twfA:99.353rqwH-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RQW_H_ACHH323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 5 / 9 | GLU A 77ILE A 79GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.66A | 3rqwH-4twfA:33.03rqwI-4twfA:33.0 | 3rqwH-4twfA:99.353rqwI-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RQW_I_ACHI323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 8 | ILE A 79GLU A 131TYR A 175PHE A 188 | NoneBR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.60A | 3rqwI-4twfA:33.03rqwJ-4twfA:33.0 | 3rqwI-4twfA:99.353rqwJ-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RQW_J_ACHJ323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 8 | GLU A 77GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)BR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.68A | 3rqwF-4twfA:33.03rqwJ-4twfA:33.0 | 3rqwF-4twfA:99.353rqwJ-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A97_A_ZPCA1318_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 5 / 7 | GLU A 77ILE A 79GLU A 131PHE A 133TYR A 175 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.1A)BR7 A 401 (-4.5A)BR7 A 401 (-3.9A) | 0.40A | 4a97A-4twfA:33.7 | 4a97A-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A97_A_ZPCA1318_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 7 | ILE A 79GLU A 131TYR A 175VAL A 181 | NoneBR7 A 401 (-4.1A)BR7 A 401 (-3.9A)None | 1.10A | 4a97A-4twfA:33.7 | 4a97A-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A97_D_ZPCD1318_2 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 5 / 7 | GLU A 77ILE A 79GLU A 131PHE A 133TYR A 175 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.1A)BR7 A 401 (-4.5A)BR7 A 401 (-3.9A) | 0.54A | 4a97D-4twfA:33.6 | 4a97D-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A97_E_ZPCE1318_2 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 6 | GLU A 131PHE A 133TYR A 175PHE A 188 | BR7 A 401 (-4.1A)BR7 A 401 (-4.5A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.55A | 4a97E-4twfA:33.7 | 4a97E-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A97_H_ZPCH1318_2 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 5 / 7 | GLU A 77ILE A 79GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.45A | 4a97H-4twfA:33.9 | 4a97H-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A97_H_ZPCH1318_2 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 7 | GLU A 131TYR A 175VAL A 181PHE A 188 | BR7 A 401 (-4.1A)BR7 A 401 (-3.9A)NoneBR7 A 401 (-3.9A) | 1.06A | 4a97H-4twfA:33.9 | 4a97H-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A97_I_ZPCI1318_2 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 6 | GLU A 77ILE A 79PHE A 133TYR A 175 | BR7 A 401 ( 4.9A)NoneBR7 A 401 (-4.5A)BR7 A 401 (-3.9A) | 0.49A | 4a97I-4twfA:33.9 | 4a97I-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A97_J_ZPCJ1318_2 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 5 | GLU A 77GLU A 131PHE A 133TYR A 175 | BR7 A 401 ( 4.9A)BR7 A 401 (-4.1A)BR7 A 401 (-4.5A)BR7 A 401 (-3.9A) | 0.57A | 4a97J-4twfA:33.7 | 4a97J-4twfA:99.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TWD_A_377A401_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 5 | GLU A 77GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)BR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.32A | 4twdA-4twfA:34.74twdE-4twfA:34.1 | 4twdA-4twfA:100.004twdE-4twfA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TWD_B_377B401_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 5 | GLU A 77GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)BR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.34A | 4twdA-4twfA:34.74twdB-4twfA:34.0 | 4twdA-4twfA:100.004twdB-4twfA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TWD_F_377F401_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 7 | GLU A 77GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)BR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.31A | 4twdF-4twfA:34.34twdJ-4twfA:33.8 | 4twdF-4twfA:100.004twdJ-4twfA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TWD_H_377H401_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 6 | GLU A 77GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)BR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.39A | 4twdG-4twfA:34.04twdH-4twfA:34.3 | 4twdG-4twfA:100.004twdH-4twfA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TWD_H_377H402_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4twf | CYS-LOOPLIGAND-GATED IONCHANNEL (Dickeyachrysanthemi) | 4 / 5 | GLU A 77GLU A 131TYR A 175PHE A 188 | BR7 A 401 ( 4.9A)BR7 A 401 (-4.1A)BR7 A 401 (-3.9A)BR7 A 401 (-3.9A) | 0.35A | 4twdH-4twfA:34.34twdI-4twfA:34.0 | 4twdH-4twfA:100.004twdI-4twfA:100.00 |